Teva Wins Three, Loses Six in Patent Battle Over Migraine Drug

Teva Wins Three, Loses Six in Patent Battle Over Migraine Drug

Source: 
BioSpace
snippet: 

In a patent infringement lawsuit filed against Eli Lilly, Teva Pharmaceuticals won three and lost six patents. The patent lawsuit was over Teva’s Ajovy (fremanezumab-vfrm) to prevent migraines. Eli Lilly has a competitive migraine drug, Emgality (galcanezumab).